This research investigates a medicinal plant as a potential treatment for prostate cancer and benign prostatic hyperplasia. Findings show reduced PSA levels, hormone regulation, and selective killing of cancer cells while sparing healthy cells. The work suggests a promising, lower-side-effect alternative to conventional therapies, improving outcomes and quality of life.

This study tests whether CBD genuinely reduces anxiety in people with social anxiety disorder. Fifty participants will receive either pharmaceutical-grade CBD or a placebo before a stressful mock interview. Researchers will measure subjective and physiological anxiety and scan participants’ brains to detect CBD’s effects, providing the first clinical evidence for or against its effectiveness.